This article has been updated to include comments from a conference call and a stock quote.
 
NEW YORK (GenomeWeb News) – Invitrogen reported after the close of the market today that its first-quarter revenues rose 13.5 percent and its profit nearly doubled.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.